Embecta to host Analyst and Investor Day on May 22, 2025
Embecta (Nasdaq: EMBC), a global diabetes care company specializing in insulin delivery, has announced its upcoming Analyst and Investor Day scheduled for May 22, 2025, from 9:00 a.m. to 12:30 p.m. in New York City.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Embecta (Nasdaq: EMBC), a global diabetes care company specializing in insulin delivery, has announced its upcoming Analyst and Investor Day scheduled for May 22, 2025, from 9:00 a.m. to 12:30 p.m. in New York City.
The event will feature presentations from President & CEO Dev Kurdikar, CFO Jake Elguicze, and other leadership team members. They will discuss:
- Strategic and business overview
- Value creation opportunities
- Company's financial profile
- Long-term objectives
While in-person attendance is by invitation only, interested parties can participate via webcast through InvestorDay.embecta.com. A replay and presentation materials will be available in the 'Events & Presentations' section of the company's Investor Relations website after the event.
Details
News Market Reaction – EMBC
The recorded move for EMBC in the trading session of this news was +3.70%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
PARSIPPANY, N.J., April 28, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will hold an Analyst and Investor Day on May 22, 2025, from 9:00 a.m. to 12:30 p.m. in New York City.
Dev Kurdikar, President & Chief Executive Officer, and Jake Elguicze, Chief Financial Officer, will be joined by members of the embecta leadership team to present strategic and business overview, including value creation opportunities, the company’s financial profile and its long-term objectives.
To register for the webcast, please go to: embecta Analyst & Investor Day Webcast Registration.
Visit InvestorDay.embecta.com to view the agenda for the event and watch the live webcast. A replay of the webcast, along with Investor Day materials, will be available on the "Events & Presentations" section of the Company's Investor Relations website following the conclusion of the event.
In-person attendance is by invitation only.
About embecta
embecta is a global diabetes care company that is leveraging its 100-year legacy in insulin delivery to empower people with diabetes to live their best life through innovative solutions, partnerships, and the passion of approximately 2,000 employees around the globe. For more information, visit embecta.com or follow our social channels on LinkedIn, Facebook, and Instagram.
Contacts:
| Media | Investors |
| Christian Glazar | Pravesh Khandelwal |
| Sr. Director, Corporate Communications | VP, Head of Investor Relations |
| 908-821-6922 | 551-264-6547 |
| Contact Media Relations | Contact IR |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.